Idea principal
Across 25 accelerometer studies, children and adolescents with heart, lung, diabetes or cancer conditions generally did less than the recommended 60 minutes a day of moderate-to-vigorous activity, and mostly matched healthy peers except those with malignancies (SMD -2.2, 95% CI -4.08 to -0.26). That malignancy result rests on only 2 studies (n = 90), and the other comparisons were not significant.
Study design
Revisión de evidencia
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Regular activity and less sitting matter for children with long-term illness, but it is unclear how active they actually are day to day. The review asked what accelerometer-measured moderate-to-vigorous physical activity (MVPA) and sedentary time look like in these children and how they compare with healthy peers.
Población y método
Systematic review and meta-analysis. Medline, Cochrane library, EMBASE, SPORTDiscus and CINAHL were searched for 2000-2017. Eligible studies used accelerometers (at least 3 days and 6 hours per day) in children aged 0-19 with chronic disease but without co-morbidities that would be major impediments to physical activity, studied while well and clinically stable. Of 1592 records, 25 studies were included: cardiovascular disease (7 studies), respiratory disease (7), diabetes (8) and malignancy (3). Patients were compared with healthy controls where such data existed.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Patients' MVPA was generally below the recommended 60 min/day and sedentary time generally high, whatever the disease.
- 2Compared with healthy controls, no marked MVPA difference was seen in cardiovascular disease (1 study, n = 42) or type 1 diabetes (5 studies, n = 400; SMD -0.70, 95% CI -1.89 to 0.48, p = 0.25).
- 3In respiratory disease, MVPA was lower than in controls, but the difference did not reach significance (4 studies, n = 470; SMD -0.39, 95% CI -0.80 to 0.02, p = 0.06).
- 4In malignancies, MVPA was significantly lower than in controls (2 studies, n = 90; SMD -2.2, 95% CI -4.08 to -0.26, p = 0.03).
- 5Sedentary time was significantly higher in patients in 4 of 10 studies, significantly lower in 1, and not different in 5.
Límites e incertidumbre
- 1The comparisons rest on few studies: 1 for cardiovascular disease and 2 for malignancy (n = 90), so the largest effect is imprecise.
- 2Wide confidence intervals mean that 'no marked difference' for type 1 diabetes and cardiovascular disease is not proof that activity is the same as in healthy children.
- 3Only children who were well and clinically stable, without major activity-limiting co-morbidities, were included, so results may not apply to those more severely ill.
- 4The abstract does not report how MVPA was defined across studies or how consistent the accelerometer methods were. This reading is based on the abstract only.
Relevancia práctica
Most of these children were reported to be well below the 60-minute guideline, though mostly comparable with healthy peers, so more daily movement is a reasonable topic to raise. Safe types and amounts depend on the condition, so activity plans belong with the child's care team. The review does not show which programs work.
Tus datos
A wrist or hip accelerometer, like many children's activity trackers, can show daily active minutes and sitting time, the kind of measure used here. Compare a child's own weeks on the same device and wear schedule, and bring a persistent shortfall from 60 minutes to the care team rather than reading it as a diagnosis.
Cómo interpretar la evidencia
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Context
Moderate-to-vigorous physical activity (MVPA) and sedentary time (ST) are important for child and adolescent health.
Objective
To examine habitual levels of accelerometer measured MVPA and ST in children and adolescents with chronic disease, and how these levels compare with healthy peers.
Methods
Data sources: An extensive search was carried out in Medline, Cochrane library, EMBASE, SPORTDiscus and CINAHL from 2000-2017. Study selection: Studies with accelerometer-measured MVPA and/or ST (at least 3 days and 6 hours/day to provide estimates of habitual levels) in children 0-19 years of age with chronic diseases but without co-morbidities that would present major impediments to physical activity. In all cases patients were studied while well and clinically stable.
Results
Out of 1592 records, 25 studies were eligible, in four chronic disease categories: cardiovascular disease (7 studies), respiratory disease (7 studies), diabetes (8 studies), and malignancy (3 studies). Patient MVPA was generally below the recommended 60 min/day and ST generally high regardless of the disease condition. Comparison with healthy controls suggested no marked differences in MVPA between controls and patients with cardiovascular disease (1 study, n = 42) and type 1 diabetes (5 studies, n = 400; SMD -0.70, 95% CI -1.89 to 0.48, p = 0.25). In patients with respiratory disease, MVPA was lower in patients than controls (4 studies, n = 470; SMD -0.39, 95% CI -0.80, 0.02, p = 0.06). Meta-analysis indicated significantly lower MVPA in patients with malignancies than in the controls (2 studies, n = 90; SMD -2.2, 95% CI -4.08 to -0.26, p = 0.03). Time spent sedentary was significantly higher in patients in 4/10 studies compared with healthy control groups, significantly lower in 1 study, while 5 studies showed no significant group difference.
Conclusions
MVPA in children/adolescents with chronic disease appear to be well below guideline recommendations, although comparable with activity levels of their healthy peers except for children with malignancies. Tailored and disease appropriate intervention strategies may be needed to increase MVPA and reduce ST in children and adolescents with chronic disease.
Fuentes y atribución
Accelerometer measured levels of moderate-to-vigorous intensity physical activity and sedentary time in children and adolescents with chronic disease: A systematic review and meta-analysis.
Elmesmari R, Reilly JJ, Martin A, Paton JY.
PloS one · 2017-06-22
DOI: 10.1371/journal.pone.0179429 ↗PubMed · 28640907 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

